Cabot Wealth Management’s Halozyme HALO Stock Holding History

Cabot Wealth Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-3,245	Closed	-$207K	–	130
2025 Q1	$207K	Buy	+3,245	New	+$189K	0.03%	127
2024 Q4	–	Sell	-66,837	Closed	-$3.83M	–	130
2024 Q3	$3.83M	Sell	66,837 -3	-0%	-$172	0.48%	55
2024 Q2	$3.5M	Sell	66,840 -104	-0.2%	-$4.56K	0.46%	57
2024 Q1	$2.72M	Buy	66,944 +1,018	+2%	+$38.2K	0.36%	62
2023 Q4	$2.44M	Buy	65,926 +19,778	+43%	+$745K	0.34%	69
2023 Q3	$1.76M	Buy	46,148 +1,793	+4%	+$73.4K	0.27%	81
2023 Q2	$1.6M	Sell	44,355 -3,846	-8%	-$131K	0.24%	83
2023 Q1	$1.84M	Sell	48,201 -1,025	-2%	-$48.1K	0.29%	78
2022 Q4	$2.8M	Buy	49,226 +16,577	+51%	+$849K	0.47%	55
2022 Q3	$1.29M	Buy	+32,649	New	+$1.44M	0.22%	81

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cabot Wealth Management's HALO Position: Q2 2025 in Review

Cabot Wealth Management sold out of Halozyme (HALO) in Q2 2025, closing a stake of 3,245 shares — an estimated $207K sold.

Cabot Wealth Management first reported a position in HALO in Q3 2022 and held it in 10 quarters. The position peaked at $3.83M in Q3 2024. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

Cabot Wealth Management reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
Cabot Wealth Management sold 3,245 Halozyme shares in Q2 2025, an estimated $207K.
Cabot Wealth Management first reported a position in Halozyme in Q3 2022 and held it in 10 quarters.
Cabot Wealth Management's Halozyme position peaked at $3.83M in Q3 2024.
551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Cabot Wealth Management's 13F filing for Q2 2025, filed 31 Jul 2025.